# Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.

> **NCT00367653** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 397 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Azithromycin plus Chloroquine
- **DRUG:** Mefloquine

## Key facts

- **NCT ID:** NCT00367653
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 397 (ACTUAL)
- **Last updated:** 2008-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367653, "Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00367653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*